Abstract
The concept of prophylactic and adjuvant regional chemotherapy of the liver in colorectal malignancies is based on the fact that 25%–30% of the patients already have linear metastases at the time of primary resection. Of those without metastases at this time, 40%–50% develop liver metastases secondarily [2,8]. In view of this, Taylor perfused the liver via the recanalized umbilical vein with 1 g 5-fiuorouracil (5-FU) per day continuously for 7 days, starting immediately after curative resection of the tumor. He observed fewer liver metastases and better survival in the perfusion group [11].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bengmark S, Hafström L, Jeppson B (1982) Metastatic disease in the liver from colorectal cancer: an appraisal of liver surgery. World J Surg 6:61–65
Denck H (1984) Ergebnisse einer intraarteriellen intermittierenden Chemotherapie mit 5-FU bei Metastasenleber sowie inoperablen Tumoren des Gastrointestinal-und Urogenitaltraktes. Onkologie 7:167–176
Gall FP, Scheele J, Herfarth C, Rothmund M, Funovics, J Siewert JR (1985) Therapiekonzept bei Lebermetastasen. Langenbecks Arch Chir 365:219–226
Ghussen F, Grundmann R, Nage K, Pichlmaier H (1985) Aktueller Stand der Therapie von Lebermetastasen kolorektaler Karzinome. Leber Magen Darm 15:76–80
Hohenberger P, Schlag P, Herfarth C (1986) Zur Indikationsstellung operativer Verfahren bei primären und sekundären malignen Lebertumoren (Kongreßericht). Langenbecks Arch Chir 369:789
Lien MW, Ackermann NB (1970) The blood supply of experimental liver metastases. II. A microcirculatory study of the normal and tumor vessels of the liver with the use of perfused silicone rubber. Surgery 68:334–340
Metzger U, Schneider K, Largiadèr P (1982) Adjuvante Therapie des Kolon-und Rektumkarzinoms. Onkologie 5:228–236
Metzger U (1985) Efforts for the prevention of liver metastases of colorectal carcinoma. Primary and secondary liver cancer. In: Herfarth C, Hohenberger P, Schlag P (eds) Therapeutic strategies in primary and metastatic liver cancer. Springer, Berlin Heidelberg New York, pp 29–34(Recent results in cancer research, vol 100)
Neuhaus P, Ringe B, Beckstein G, Pichlmayr R (1986) Ergebnisse und Bedeutung der Resektion von Lebermetastasen colorectaler Tumoren (Kongreßbericht). Langenbecks Arch Chir 369:789–790
Schlag P (1985) Die Chemotherapie im Rahmen der operativen Primär-und Rezidivbehandlung des colorectalen Karzinoms. Onkol Forum 3:5–8
Taylor J, Rowling JT (1979) Adjuvant cytotoxic liver perfusion for colorectal cancer. Br J Surg 66:833–837
Wolff H, Lippert H, Sterling P (1985) Die chirurgische Therapie von Lebertumoren. Klinikarzt 14:610–620
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Gruenagel, H.H., Molzahn, E., Neumann, S., Neukamp, GU. (1990). Prophylactic and Adjuvant Regional Chemotherapy of the Liver in Colorectal Malignancies. In: Jakesz, R., Rainer, H. (eds) Progress in Regional Cancer Therapy. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74818-9_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-74818-9_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-74820-2
Online ISBN: 978-3-642-74818-9
eBook Packages: Springer Book Archive